Search results
Results from the WOW.Com Content Network
Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [ 10 ] [ 11 ] [ 12 ] Specifically it is used to prevent rather than treat asthma attacks. [ 10 ]
The International Organization for Migration (IOM) is a United Nations related organization working in the field of migration. The organization implements operational assistance programmes for migrants, including internally displaced persons, refugees, and migrant workers. The International Organization for Migration is a UN agency based in Geneva.
The methasones (or metasones) are a class of corticosteroids [1] which are generally used in dermatology.They are defined by substitution with a methyl group at the C16α or C16β position of the pregnane steroid nucleus.
Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]
International Organisation for Migration. ... International Organization for Migration; ... Text is available under the Creative Commons Attribution-ShareAlike 4.0 ...
[1] The organization has been proposed by academics and researchers such as Professor Jagdish Bhagwati and Arthur Helton [2] and discussed by organizations such as the Global Commission on International Migration (GCIM), the International Organization for Migration (IOM), the World Bank and others. [3] [4] [5]
The other two members of the society were the Centre on Migration, Policy and Society (COMPAS) and the Refugee Studies Centre (RSC). [7] [8] IMI was also a collaborator to the International Organization for Migration (IOM). [9] It was also listed as a partner for the migration program of the Social Science Research Council. [10]
It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. [11] An optional electronic sensor may also be co-packed with the product. [11]